The N-Terminal Flanking Region of the Invariant Chain Peptide Augments the Immunogenicity of a Cryptic “Self” Epitope from a Tumor-Associated Antigen

By Hess A.D.   Thoburn C.   Chen W.   Miura Y.   van der Wall E.  

Clinical Immunology, Vol. 101, Iss. 1, 2001-10 ,pp. : 67-76

Academic Press

Access to resources Recommend Favorite

Tuning tumor-specific T-cell activation: a matter of costimulation?

By Abken H.   Hombach A.   Heuser C.   Kronfeld K.   Seliger B.  

Trends in Immunology, Vol. 23, Iss. 5, 2002-05 ,pp. : 240-245

Elsevier

Access to resources Recommend Favorite

Induction of Cell-Mediated Immune Responses to Peptide Antigens of P. vivax in Microparticles Using Intranasal Immunization

By Bhat Ajaz A.   Seth Ratnesh K.   Kumar Sudhir   Ali Riyasat   Mohan Teena   Biswas Sukla   Rao D. N.  

Immunological Investigations, Vol. 39, Iss. 4-5, 2010-01 ,pp. : 483-499

Informa Healthcare

Access to resources Recommend Favorite

Determinant spreading and tumor responses after peptide-based cancer immunotherapy

By Ribas A.   Timmerman J.M.   Butterfield L.H.   Economou J.S.  

Trends in Immunology, Vol. 24, Iss. 2, 2003-02 ,pp. : 58-61

Elsevier

Access to resources Recommend Favorite

Immunization in tumor prevention

By Forni G.   Curcio C.   Spadaro M.   Iliffe J.   Quaglino E.   Di Carlo E.   Musiani P.   Lollini P.-L.  

International Immunopharmacology, Vol. 3, Iss. 8, 2003-08 ,pp. : 1151-1158

Elsevier

Access to resources Recommend Favorite